Epigallocatechin gallate protects against homocysteine-induced vascular smooth muscle cell proliferation.

about

Epigallocatechin gallate protects against homocysteine-induced vascular smooth muscle cell proliferation.

Item

http://www.wikidata.org/entity/Q47856576

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Epigallocatechin gallate prote ...... oth muscle cell proliferation.

@en

Epigallocatechin gallate prote ...... oth muscle cell proliferation.

@nl

type

Item

label

Epigallocatechin gallate prote ...... oth muscle cell proliferation.

@en

Epigallocatechin gallate prote ...... oth muscle cell proliferation.

@nl

prefLabel

Epigallocatechin gallate prote ...... oth muscle cell proliferation.

@en

Epigallocatechin gallate prote ...... oth muscle cell proliferation.

@nl

P1476

Epigallocatechin gallate prote ...... oth muscle cell proliferation.

@en

P2093

Hui Min Jin

http://www.w3.org/2001/XMLSchema#string

Li Li Guo

http://www.w3.org/2001/XMLSchema#string

Xiao Li Zhan

http://www.w3.org/2001/XMLSchema#string

Xiu Hong Yang

http://www.w3.org/2001/XMLSchema#string

Yan Hong Gu

http://www.w3.org/2001/XMLSchema#string

P2860

Activation and function of the MAPKs and their substrates, the MAPK-activated protein kinases

CCN5 is a growth arrest-specific gene that regulates smooth muscle cell proliferation and motility

Atherosclerosis — An Inflammatory Disease

Role of angiotensin II in cardiovascular disease therapeutic implications of more than a century of research

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease.

Effects of green tea and EGCG on cardiovascular and metabolic health.

Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research.

Local angiotensin II aggravates cardiac remodeling in hypertension.

Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis.

Prevalence of anemia in chronic kidney disease in the United States.

P2888

s11010-017-3142-6

P304

131-140

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11010-017-3142-6

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

439

http://www.w3.org/2001/XMLSchema#string

P577

2017-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28871467

http://www.w3.org/2001/XMLSchema#string